Neoantigen Cancer Vaccine Market

The global neoantigen cancer vaccine market was valued at USD 475.68 million in 2025 and is forecasted to escalate impressively to approximately USD 1,799.21 million by 2034, representing a compounded annual growth rate (CAGR) of 15.93% from 2025 to 2034. This promising growth is driven by the rising global burden of cancer, increased government investments […]